1. Home
  2. MERC vs AARD Comparison

MERC vs AARD Comparison

Compare MERC & AARD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MERC
  • AARD
  • Stock Information
  • Founded
  • MERC 1968
  • AARD 2017
  • Country
  • MERC Canada
  • AARD United States
  • Employees
  • MERC N/A
  • AARD N/A
  • Industry
  • MERC Paper
  • AARD Biotechnology: Pharmaceutical Preparations
  • Sector
  • MERC Basic Materials
  • AARD Health Care
  • Exchange
  • MERC Nasdaq
  • AARD Nasdaq
  • Market Cap
  • MERC 271.5M
  • AARD 242.9M
  • IPO Year
  • MERC 1987
  • AARD 2025
  • Fundamental
  • Price
  • MERC $3.25
  • AARD $9.77
  • Analyst Decision
  • MERC Hold
  • AARD Strong Buy
  • Analyst Count
  • MERC 3
  • AARD 5
  • Target Price
  • MERC $4.67
  • AARD $32.80
  • AVG Volume (30 Days)
  • MERC 1.4M
  • AARD 48.9K
  • Earning Date
  • MERC 07-31-2025
  • AARD 08-13-2025
  • Dividend Yield
  • MERC 9.22%
  • AARD N/A
  • EPS Growth
  • MERC N/A
  • AARD N/A
  • EPS
  • MERC N/A
  • AARD N/A
  • Revenue
  • MERC $1,951,044,000.00
  • AARD N/A
  • Revenue This Year
  • MERC $2.43
  • AARD N/A
  • Revenue Next Year
  • MERC $6.12
  • AARD N/A
  • P/E Ratio
  • MERC N/A
  • AARD N/A
  • Revenue Growth
  • MERC N/A
  • AARD N/A
  • 52 Week Low
  • MERC $2.59
  • AARD $4.88
  • 52 Week High
  • MERC $8.28
  • AARD $19.58
  • Technical
  • Relative Strength Index (RSI)
  • MERC 48.72
  • AARD N/A
  • Support Level
  • MERC $2.94
  • AARD N/A
  • Resistance Level
  • MERC $3.24
  • AARD N/A
  • Average True Range (ATR)
  • MERC 0.20
  • AARD 0.00
  • MACD
  • MERC 0.03
  • AARD 0.00
  • Stochastic Oscillator
  • MERC 85.71
  • AARD 0.00

About MERC Mercer International Inc.

Mercer International Inc is a forest products company with two reportable operating segments in pulp and solid wood. The pulp segment consists of the manufacture, sale, and distribution of pulp, electricity, and chemicals. The company has a geographical presence in the USA, Germany, China, and Other countries, where the majority of revenue is generated from the USA. The majority of the revenue is generated from the Pulp segment.

About AARD Aardvark Therapeutics Inc. Common Stock

Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.

Share on Social Networks: